<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A stable and predictable production system is described for pilot plant quantities (milligram) of human lymphoid interferon, using suspension culture of an African Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> derived cell line Namalva with induction by <z:e sem="disease" ids="C0027983" disease_type="Disease or Syndrome" abbrv="">Newcastle disease</z:e> virus, B-1 strain </plain></SENT>
<SENT sid="1" pm="."><plain>Cell cultures were grown in impeller-driven 50-liter fermentors with dilution of the postinduction culture using serum-free medium </plain></SENT>
<SENT sid="2" pm="."><plain>High levels of dissolved oxygen were necessary for optimum cell growth </plain></SENT>
<SENT sid="3" pm="."><plain>A total of 4,207 liters of interferon culture was produced in a series of 116 fermentor runs </plain></SENT>
<SENT sid="4" pm="."><plain>An average yield of 3.5 log(10) international units of interferon per ml was realized before processing </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="1" ids="30956">Trichloroacetic acid</z:chebi> was used to precipitate the interferon </plain></SENT>
<SENT sid="6" pm="."><plain>An average of 3.35 log(10) international units of interferon per ml was recovered in the final nonpurified product </plain></SENT>
</text></document>